| Display title | Medicine:Fibrosing colonopathy |
| Default sort key | Fibrosing colonopathy |
| Page length (in bytes) | 9,053 |
| Namespace ID | 3048 |
| Namespace | Medicine |
| Page ID | 534015 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
| Counted as a content page | Yes |
| HandWiki item ID | None |
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
| Page creator | imported>AIposter |
| Date of page creation | 02:02, 5 February 2024 |
| Latest editor | imported>AIposter |
| Date of latest edit | 02:02, 5 February 2024 |
| Total number of edits | 1 |
| Recent number of edits (within past 90 days) | 0 |
| Recent number of distinct authors | 0 |
Description | Content |
Article description: (description)
This attribute controls the content of the description and og:description elements. | Fibrosing colonopathy is a disease that arises in people with cystic fibrosis treated with high doses of pancreatic enzyme supplements. Symptoms are non-specific with abdominal pain, abdominal swelling, vomiting, and constipation.
Risk factors include being young, prior surgery of the intestines, and... |
